Affimed NV (AFMD)
3.65
-0.08
(-2.28%)
USD |
NASDAQ |
Nov 14, 16:00
3.65
0.00 (0.00%)
After-Hours: 20:00
Affimed Revenue (Quarterly): 0.1658M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1658M |
| March 31, 2024 | 0.1684M |
| December 31, 2023 | 0.4448M |
| September 30, 2023 | 2.136M |
| June 30, 2023 | 1.516M |
| March 31, 2023 | 4.844M |
| December 31, 2022 | 11.41M |
| September 30, 2022 | 15.00M |
| June 30, 2022 | 7.777M |
| March 31, 2022 | 8.984M |
| December 31, 2021 | 11.82M |
| September 30, 2021 | 10.21M |
| June 30, 2021 | 11.70M |
| March 31, 2021 | 14.05M |
| December 31, 2020 | 11.62M |
| September 30, 2020 | 12.33M |
| June 30, 2020 | 3.231M |
| March 31, 2020 | 5.667M |
| December 31, 2019 | 4.348M |
| September 30, 2019 | 2.338M |
| June 30, 2019 | 4.503M |
| March 31, 2019 | 12.90M |
| December 31, 2018 | 25.95M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.3558M |
| June 30, 2018 | 0.1791M |
| March 31, 2018 | 0.6536M |
| December 31, 2017 | 0.749M |
| September 30, 2017 | 0.549M |
| June 30, 2017 | 0.5589M |
| March 31, 2017 | 0.425M |
| December 31, 2016 | 1.479M |
| September 30, 2016 | 1.047M |
| June 30, 2016 | 2.338M |
| March 31, 2016 | 2.136M |
| December 31, 2015 | 1.815M |
| September 30, 2015 | 1.284M |
| June 30, 2015 | 2.442M |
| March 31, 2015 | 2.864M |
| December 31, 2014 | 0.1012M |
| September 30, 2014 | 2.507M |
| June 30, 2014 | 0.9423M |
| March 31, 2014 | 0.9891M |
| December 31, 2013 | 6.296M |
| September 30, 2013 | 0.2532M |
| June 30, 2013 | 0.2625M |
| March 31, 2013 | 0.0924M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.1658M
Minimum
Jun 2024
15.00M
Maximum
Sep 2022
7.233M
Average
7.777M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| InflaRx NV | 0.0068M |
| BioNTech SE | 1.369B |
| Immatics NV | 20.19M |
| CureVac NV | 15.54M |
| ATAI Life Sciences NV | 0.273M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.64M |
| Total Expenses (Quarterly) | 16.97M |
| EPS Diluted (Quarterly) | -1.088 |
| Enterprise Value | 30.82M |
| Profit Margin (Quarterly) | -10.03K% |
| Earnings Yield | -156.3% |
| Normalized Earnings Yield | -160.93 |